The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Prothrombin Time

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Prothrombin Time


Psychiatry related information on Prothrombin Time


High impact information on Prothrombin Time


Chemical compound and disease context of Prothrombin Time


Biological context of Prothrombin Time


Anatomical context of Prothrombin Time


Associations of Prothrombin Time with chemical compounds


Gene context of Prothrombin Time


Analytical, diagnostic and therapeutic context of Prothrombin Time


  1. Aminopyrine N-demethylation: a prognostic test of liver function in patients with alcoholic liver disease. Schneider, J.F., Baker, A.L., Haines, N.W., Hatfield, G., Boyer, J.L. Gastroenterology (1980) [Pubmed]
  2. Spironolactone and enzyme induction in patients with alcoholic cirrhosis. Miguet, J.P., Vuitton, D., Thebault-Lucas, A., Joanne, C., Dhumeaux, D. Gastroenterology (1980) [Pubmed]
  3. Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial. Carithers, R.L., Herlong, H.F., Diehl, A.M., Shaw, E.W., Combes, B., Fallon, H.J., Maddrey, W.C. Ann. Intern. Med. (1989) [Pubmed]
  4. Monitoring warfarin therapy in patients with lupus anticoagulants. Moll, S., Ortel, T.L. Ann. Intern. Med. (1997) [Pubmed]
  5. Comparison of native prothrombin antigen with the prothrombin time for monitoring oral anticoagulant prophylaxis. Kornberg, A., Francis, C.W., Pellegrini, V.D., Gabriel, K.R., Marder, V.J. Circulation (1993) [Pubmed]
  6. Medium-chain and long-chain acyl CoA dehydrogenase deficiency: clinical, pathologic and ultrastructural differentiation from Reye's syndrome. Treem, W.R., Witzleben, C.A., Piccoli, D.A., Stanley, C.A., Hale, D.E., Coates, P.M., Watkins, J.B. Hepatology (1986) [Pubmed]
  7. Management of acute and fulminant hepatitis A. O'Grady, J. Vaccine (1992) [Pubmed]
  8. The effect of chronic alcohol intake on prognosis and outcome in paracetamol overdose. Bray, G.P., Mowat, C., Muir, D.F., Tredger, J.M., Williams, R. Human & experimental toxicology. (1991) [Pubmed]
  9. Anorexia nervosa with severe liver dysfunction and subsequent critical complications. Furuta, S., Ozawa, Y., Maejima, K., Tashiro, H., Kitahora, T., Hasegawa, K., Kuroda, S., Ikuta, N. Intern. Med. (1999) [Pubmed]
  10. Heparin as an antithrombotic agent. Low-dose prophylaxis. Wessler, S. JAMA (1976) [Pubmed]
  11. High-density lipoprotein enhancement of anticoagulant activities of plasma protein S and activated protein C. Griffin, J.H., Kojima, K., Banka, C.L., Curtiss, L.K., Fernández, J.A. J. Clin. Invest. (1999) [Pubmed]
  12. Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase. Angus, P., Vaughan, R., Xiong, S., Yang, H., Delaney, W., Gibbs, C., Brosgart, C., Colledge, D., Edwards, R., Ayres, A., Bartholomeusz, A., Locarnini, S. Gastroenterology (2003) [Pubmed]
  13. Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation. Bock, C.T., Tillmann, H.L., Torresi, J., Klempnauer, J., Locarnini, S., Manns, M.P., Trautwein, C. Gastroenterology (2002) [Pubmed]
  14. Prevention of one-year vein-graft occlusion after aortocoronary-bypass surgery: a comparison of low-dose aspirin, low-dose aspirin plus dipyridamole, and oral anticoagulants. The CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands. van der Meer, J., Hillege, H.L., Kootstra, G.J., Ascoop, C.A., Mulder, B.J., Pfisterer, M., van Gilst, W.H., Lie, K.I. Lancet (1993) [Pubmed]
  15. Comparison of serum procollagen III peptide concentrations and PGA index for assessment of hepatic fibrosis. Teare, J.P., Sherman, D., Greenfield, S.M., Simpson, J., Bray, G., Catterall, A.P., Murray-Lyon, I.M., Peters, T.J., Williams, R., Thompson, R.P. Lancet (1993) [Pubmed]
  16. S-adenosylhomocysteine hydrolase deficiency in a human: a genetic disorder of methionine metabolism. Baric, I., Fumic, K., Glenn, B., Cuk, M., Schulze, A., Finkelstein, J.D., James, S.J., Mejaski-Bosnjak, V., Pazanin, L., Pogribny, I.P., Rados, M., Sarnavka, V., Scukanec-Spoljar, M., Allen, R.H., Stabler, S., Uzelac, L., Vugrek, O., Wagner, C., Zeisel, S., Mudd, S.H. Proc. Natl. Acad. Sci. U.S.A. (2004) [Pubmed]
  17. Preventive and therapeutic approach to venous thromboembolic disease and pulmonary embolism--can death from pulmonary embolism be prevented? Kakkar, V.V., Adams, P.C. J. Am. Coll. Cardiol. (1986) [Pubmed]
  18. Hypoprothrombinemia associated with cefamandole use in a rural teaching hospital. Bertino, J.S., Kozak, A.J., Reese, R.E., Chiarello, L.A. Arch. Intern. Med. (1986) [Pubmed]
  19. Effects of low dose aspirin (50 mg/day), low dose aspirin plus dipyridamole, and oral anticoagulant agents after internal mammary artery bypass grafting: patency and clinical outcome at 1 year. CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands. Prevention of Coronary Artery Bypass Graft Occlusion by Aspirin, Dipyridamole and Acenocoumarol/Phenprocoumon Study. van der Meer, J., Brutel de la Rivière, A., van Gilst, W.H., Hillege, H.L., Pfisterer, M., Kootstra, G.J., Dunselman, P.H., Mulder, B.J., Lie, K.I. J. Am. Coll. Cardiol. (1994) [Pubmed]
  20. Abnormal hepatic sinusoidal bile acid transport in an Amish kindred is not linked to FIC1 and is improved by ursodiol. Morton, D.H., Salen, G., Batta, A.K., Shefer, S., Tint, G.S., Belchis, D., Shneider, B., Puffenberger, E., Bull, L., Knisely, A.S. Gastroenterology (2000) [Pubmed]
  21. Factor XI-dependence of surface- and tissue factor-initiated thrombus propagation in primates. Gruber, A., Hanson, S.R. Blood (2003) [Pubmed]
  22. Serial antipyrine clearance studies detect altered hepatic metabolic function during spontaneous and interferon-induced changes in chronic hepatitis B disease activity. Williams, S.J., Farrell, G.C. Hepatology (1989) [Pubmed]
  23. Activation of blood coagulation factor X by arginine-specific cysteine proteinases (gingipain-Rs) from Porphyromonas gingivalis. Imamura, T., Potempa, J., Tanase, S., Travis, J. J. Biol. Chem. (1997) [Pubmed]
  24. Fresh frozen plasma supplement to massive red blood cell transfusion. Martin, D.J., Lucas, C.E., Ledgerwood, A.M., Hoschner, J., McGonigal, M.D., Grabow, D. Ann. Surg. (1985) [Pubmed]
  25. Antiphospholipid antibodies accelerate plasma coagulation by inhibiting annexin-V binding to phospholipids: a "lupus procoagulant" phenomenon. Rand, J.H., Wu, X.X., Andree, H.A., Ross, J.B., Rusinova, E., Gascon-Lema, M.G., Calandri, C., Harpel, P.C. Blood (1998) [Pubmed]
  26. Preoperative portal vein embolization: an audit of 84 patients. Imamura, H., Shimada, R., Kubota, M., Matsuyama, Y., Nakayama, A., Miyagawa, S., Makuuchi, M., Kawasaki, S. Hepatology (1999) [Pubmed]
  27. Hepatocellular carcinoma in Central Europe: prognostic features and survival. Schöniger-Hekele, M., Müller, C., Kutilek, M., Oesterreicher, C., Ferenci, P., Gangl, A. Gut (2001) [Pubmed]
  28. Utilization and metabolic effects of a conventional and a single-solution regimen in postoperative total parenteral nutrition. Jacobson, S., Christenson, I., Kager, L., Kallner, A., Ljungdahl, I. Am. J. Clin. Nutr. (1981) [Pubmed]
  29. Hypothermia in the sepsis syndrome and clinical outcome. The Methylprednisolone Severe Sepsis Study Group. Clemmer, T.P., Fisher, C.J., Bone, R.C., Slotman, G.J., Metz, C.A., Thomas, F.O. Crit. Care Med. (1992) [Pubmed]
  30. Prolongation of prothrombin time and severe gastrointestinal bleeding associated with combined use of warfarin and ketoprofen. Flessner, M.F., Knight, H. JAMA (1988) [Pubmed]
  31. Effect of proctocolectomy for chronic ulcerative colitis on the natural history of primary sclerosing cholangitis. Cangemi, J.R., Wiesner, R.H., Beaver, S.J., Ludwig, J., MacCarty, R.L., Dozois, R.R., Zinsmeister, A.R., LaRusso, N.F. Gastroenterology (1989) [Pubmed]
  32. Synthetic heparin analogue and prothrombin time. Kakkar, V.V., Djazaeri, B., Scully, M., Weerasinghe, K. Lancet (1981) [Pubmed]
  33. Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine. Harrison, P.M., Keays, R., Bray, G.P., Alexander, G.J., Williams, R. Lancet (1990) [Pubmed]
  34. Intestinal malabsorption of vitamin E in primary biliary cirrhosis. Sokol, R.J., Kim, Y.S., Hoofnagle, J.H., Heubi, J.E., Jones, E.A., Balistreri, W.F. Gastroenterology (1989) [Pubmed]
  35. Recombinant lipoprotein-associated coagulation inhibitor inhibits tissue thromboplastin-induced intravascular coagulation in the rabbit. Day, K.C., Hoffman, L.C., Palmier, M.O., Kretzmer, K.K., Huang, M.D., Pyla, E.Y., Spokas, E., Broze, G.J., Warren, T.G., Wun, T.C. Blood (1990) [Pubmed]
  36. Expression of Wilms' tumor suppressor in the liver with cirrhosis: relation to hepatocyte nuclear factor 4 and hepatocellular function. Berasain, C., Herrero, J.I., García-Trevijano, E.R., Avila, M.A., Esteban, J.I., Mato, J.M., Prieto, J. Hepatology (2003) [Pubmed]
  37. Interferon alpha induces disorder of lipid metabolism by lowering postheparin lipases and cholesteryl ester transfer protein activities in patients with chronic hepatitis C. Shinohara, E., Yamashita, S., Kihara, S., Hirano, K., Ishigami, M., Arai, T., Nozaki, S., Kameda-Takemura, K., Kawata, S., Matsuzawa, Y. Hepatology (1997) [Pubmed]
  38. Elevation of serum interleukin 8 levels in acetaminophen overdose in children and adolescents. James, L.P., Farrar, H.C., Darville, T.L., Sullivan, J.E., Givens, T.G., Kearns, G.L., Wasserman, G.S., Simpson, P.M., Hinson, J.A. Clin. Pharmacol. Ther. (2001) [Pubmed]
  39. A novel functional assay of protein C in human plasma and its comparison with amidolytic and anticoagulant assays. Guglielmone, H.A., Vides, M.A. Thromb. Haemost. (1992) [Pubmed]
  40. Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer. Levine, M., Hirsh, J., Gent, M., Arnold, A., Warr, D., Falanga, A., Samosh, M., Bramwell, V., Pritchard, K.I., Stewart, D. Lancet (1994) [Pubmed]
  41. Aspirin hepatotoxicity and disseminated intravascular coagulation. Sbarbaro, J.A., Bennett, R.M. Ann. Intern. Med. (1977) [Pubmed]
  42. Preoperative screening: value of previous tests. Macpherson, D.S., Snow, R., Lofgren, R.P. Ann. Intern. Med. (1990) [Pubmed]
  43. Development of the human coagulation system in the full-term infant. Andrew, M., Paes, B., Milner, R., Johnston, M., Mitchell, L., Tollefsen, D.M., Powers, P. Blood (1987) [Pubmed]
  44. Optimal timing of liver transplantation for primary biliary cirrhosis. Kim, W.R., Wiesner, R.H., Therneau, T.M., Poterucha, J.J., Porayko, M.K., Evans, R.W., Klintmalm, G.B., Crippin, J.S., Krom, R.A., Dickson, E.R. Hepatology (1998) [Pubmed]
WikiGenes - Universities